Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;25(3):618-26.
doi: 10.1002/pro.2855. Epub 2015 Dec 24.

Chimeric human mitochondrial PheRS exhibits editing activity to discriminate nonprotein amino acids

Affiliations

Chimeric human mitochondrial PheRS exhibits editing activity to discriminate nonprotein amino acids

Ekaterine Kartvelishvili et al. Protein Sci. 2016 Mar.

Abstract

Mitochondria are considered as the primary source of reactive oxygen species (ROS) in nearly all eukaryotic cells during respiration. The harmful effects of these compounds range from direct neurotoxicity to incorporation into proteins producing aberrant molecules with multiple physiological problems. Phenylalanine exposure to ROS produces multiple oxidized isomers: tyrosine, Levodopa, ortho-Tyr, meta-Tyr (m-Tyr), and so on. Cytosolic phenylalanyl-tRNA synthetase (PheRS) exerts control over the translation accuracy, hydrolyzing misacylated products, while monomeric mitochondrial PheRS lacks the editing activity. Recently we showed that "teamwork" of cytosolic and mitochondrial PheRSs cannot prevent incorporation of m-Tyr and l-Dopa into proteins. Here, we present human mitochondrial chimeric PheRS with implanted editing module taken from EcPheRS. The monomeric mitochondrial chimera possesses editing activity, while in bacterial and cytosolic PheRSs this type of activity was detected for the (αβ)2 architecture only. The fusion protein catalyzes aminoacylation of tRNA(Phe) with cognate phenylalanine and effectively hydrolyzes the noncognate aminoacyl-tRNAs: Tyr-tRNA(Phe) and m-Tyr-tRNA(Phe) .

Keywords: ROS-damaged amino acid; aminoacyl-tRNA synthetases; aminoacylation; chimera; editing; fusion protein.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Editing activity of EMD fragments of EcPheRS against Tyr‐tRNAPhe: (A) B1–B5 and (B) B1–B4. Reactions were performed with 1.2 µM Tyr‐tRNAPhe prepared from in vitro transcribed E. coli tRNAPhe, with the addition of 4 µM B1–B5, 4 µM B1–B4, and 1.2 µM chimera or in the absence of enzyme.
Figure 2
Figure 2
(A) “Closed” and (B) “Open” conformations of HmstPheRS. The “Open” conformation is depicted in complex with tRNAPhe (PDB codes: 3MCQ and 3TUP accordingly). CAM colored green, ABD colored yellow, while tRNA complexed with “Open” state of HmstPheRS colored brown.
Figure 3
Figure 3
Overview of assembly process for human mitochondrial chimeric PheRS. (A) Structural module EMD from EcPheRS. Components of the module–structural domains B1–B5 depicted in different colors and marked accordingly. (B) Overall structure of the HsmtPheRS enzyme in “closed” inactive conformation. (C) The 3D‐model of human mitochondrial chimeric PheRS ribbon representation. (D) The 3D‐model space‐filling representation.
Figure 4
Figure 4
Interface area in the “closed” inactive configuration of HsmtPheRS. CAM is colored blue, while ABD is colored green. Long stretch of aa (11 aa) connecting CAM and ABD colored red. Interface area is outlined by oval colored grey.
Figure 5
Figure 5
Aminoacylation and editing activities of chimera protein in comparison with various wild‐type PheRSs: (A) Charging of E. coli tRNAPhe transcript (0.8 μM) with Phe by chimera (0.4 µM) or HsmtPheRS (0.4 µM). Reactions were performed at 37°C in the presence of 5 mM ATP and 4 μM [3H]Phe; (B) Editing activities of chimera (1 µM) and EcPheRS (20 nM) toward exogenous Tyr‐tRNAPhe (1.2 μM); (C) Reaminoacylation of m‐Tyr‐tRNAPhe with Phe by chimera or HsmtPheRS. The E. coli tRNAPhe transcript was preaminoacylated with m‐Tyr and purified, then incubated (at 1.2 µM concentration) in the presence of ATP, [3H]Phe, and chimera (0.4 μM) or HsmtPheRS (0.4 µM).

References

    1. Ibba M, Soll D (2000) Aminoacyl‐tRNA synthesis. Annu Rev Biochem 69:617–650. - PubMed
    1. Eldred EW, Schimmel PR (1972) Rapid deacylation by isoleucyl transfer ribonucleic acid synthetase of isoleucine‐specific transfer ribonucleic acid aminoacylated with valine. J Biol Chem 247:2961–2964. - PubMed
    1. Fersht AR (1977) Editing mechanisms in protein synthesis. Rejection of valine by the isoleucyl‐tRNA synthetase. Biochemistry 16:1025–1030. - PubMed
    1. Jakubowski H. Accuracy of aminoacyl‐tRNA synthetases: proofreading of amino acids In: Ibba M, Francklyn C, Cusack S, Eds. (2005) Aminoacyl‐tRNA synthetases. LANDES Bioscience, Georgetown, Texas, USA pp. 384–396.
    1. Perona JJ, Gruic‐Sovulj I Synthetic and editing mechanisms of aminoacyl‐tRNA synthetases In Topics in current chemistry. (2014) Springer‐Verlag: Berlin‐Heidelberg, pp. 1–41. - PubMed

Publication types

MeSH terms

LinkOut - more resources